Malaysia's IJN first to use dual-energy cardiac ablation tech
Translated from Malay, summarized and contextualized by DistantNews.
At a glance
- Institut Jantung Negara (IJN) is the first hospital in Malaysia to use the TactiFlex Duo Dual-Energy Cardiac Ablation Catheter.
- This new technology allows specialists to use both radiofrequency (RF) and pulsed field ablation (PFA) energy sources in a single procedure for complex heart rhythm disorders.
- The dual-energy capability enables doctors to precisely tailor treatments based on individual patient anatomy and clinical needs, enhancing care for conditions like atrial fibrillation and ventricular arrhythmias.
Institut Jantung Negara (IJN) has introduced a groundbreaking dual-energy cardiac ablation technology, making it the first hospital in Malaysia to adopt the TactiFlex Duo Cardiac Ablation Catheter. This advanced system is designed to treat complex heart rhythm disorders, including atrial fibrillation and ventricular arrhythmias, by enabling specialists to utilize both radiofrequency (RF) and pulsed field ablation (PFA) energy sources within a single procedure.
Datuk Dr. Azlan Hussin, Clinical Director of Interventional Electrophysiology and Implantable Devices at IJN, highlighted the flexibility this dual-energy capability offers. "This technology gives doctors the flexibility to switch between PFA and RF energy during the procedure, helping to treat complex heart rhythm disorders like atrial fibrillation and ventricular tachycardia," he stated. He emphasized that each patient's condition is unique, making the ability to customize ablation therapy crucial, especially for challenging cases.
The new technology complements IJN's existing ablation systems, providing an additional treatment option aimed at improving procedural outcomes and patient care. Patients experiencing persistent symptoms despite conventional treatments may benefit from this more personalized approach. IJN CEO Prof. Datuk Seri Dr. Mohamed Ezani Md. Taib affirmed the hospital's commitment to integrating the latest cardiovascular innovations into clinical practice. "Every new technology introduced at IJN is evaluated based on clinical need, patient safety, and its potential to improve treatment outcomes," he said, ensuring that patients in Malaysia have access to modern treatment options supported by experienced medical teams.
Originally published by Utusan Malaysia in Malay. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.